ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006

White House Backs Down FY 86 Cuts, Says Now They Will Be Limited To Trimming Indirect Costs

January 10, 1986

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology

April 28, 1978

Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split

April 5, 1991